demonstrated that depletion of CD163+ macrophages with doxorubicin-loaded, antibody-conjugated lipid nanoparticles inhibited tumor growth in an intraperitoneal metastasis model of melanoma (107). This evidence concerns the gene CD163 and neoplasm.